Premium
Genetic technologies, health care policy and the patent bargain
Author(s) -
Caulfield TA,
Knoppers BM,
Gold ER,
Sheremeta LE,
Bridge PJ
Publication year - 2003
Publication title -
clinical genetics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.543
H-Index - 102
eISSN - 1399-0004
pISSN - 0009-9163
DOI - 10.1034/j.1399-0004.2003.630103.x
Subject(s) - commercialization , health care , genetic engineering , value (mathematics) , business , political science , economic growth , economics , law , gene , biology , genetics , machine learning , computer science
The idea of granting patents on human genetic material continues to cause controversy. The debate is largely focussed on the moral acceptability of human gene patents, the impact of gene patents on the research environment and the value of patents to stimulate innovation and the commercialization and dissemination of genetic discoveries. As highlighted by a recent controversy in Canada, patents can also have a profound effect on health policy and access to genetic services. Creative and bold patent reform initiatives are necessary to ensure that society will, to the highest degree possible, reap the health care benefits of the genetic revolution.